-
1Academic Journal
Authors: G. V. Shmarina, D. A. Pukhalskaya, A. M. Bukina, L. V. Avakian, S. U. Semykin, E. L. Amelina, S. A. Krasovskiy, M. V. Usacheva, V. A. Alioshkin, Г. В. Шмарина, Д. А. Пухальская, А. М. Букина, Л. В. Авакян, С. Ю. Семыкин, Е. Л. Амелина, С. А. Красовский, М. Ю. Усачева, В. А. Алешкин
Source: Medical Genetics; Том 16, № 1 (2017); 37-45 ; Медицинская генетика; Том 16, № 1 (2017); 37-45 ; 2073-7998
Subject Terms: interferon-gamma, полиморфизм генов TNF, цитокины, сахарный диабет при муковисцидозе, фактор некроза опухолей-альфа, лимфотоксин-альфа, интерлейкин-17, интерферон-гамма, cystic fibrosis, TNF gene polymorphisms, cytokines, cystic fibrosis associated diabetes, tumor necrosis factor-alpha, lymphotoxin-alpha, interleukin-17
File Description: application/pdf
Relation: https://www.medgen-journal.ru/jour/article/view/228/190; O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009; 373(9678):1891-1904.; Deakin JE, Papenfuss AT, Belov K, et al. Evolution and comparative analysis of the MHC Class III inflammatory region. BMC Genomics. 2006; 7:281-294.; Bazzoni F and Beutler B: The tumor necrosis factor ligand and receptor families. N Engl J Med. 1996; 334: 1717-1725.; Kelker HC, Oppenheim JD, Stone-Wolff D, et al. Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin. Int J Cancer. 1985; 36(1):69-73.; Upadhyay V, Fu YX. Linking the microbiota and metabolic disease with lymphotoxin. Int Immunol. 2013; 25(7): 397-403.; Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997; 94: 3195-3199.; McGuire W, Hill AVS, Allsopp CEM, et al. Variation in the TNF-a promoter region associated with susceptibility to cerebral malaria. Nature. 1994; 371: 508-511.; Cabrera M, Shu MA, Shrpless C et al. Polymorphism in tumor necrosis factor genes associated with cocutaneous leishmaniasis. J Exp Med. 1995; 182: 1259-1264.; Moffatt MF, Cookson WO. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet. 1997; 6: 551-554.; Shaw MA, Donaldson IJ, Collins A, et al. Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes Immun. 2001; 2: 196-204.; Babic Z, Pipinic IS, Varnai VM, et al. Association of TNFa - 308G>A, TNFa - 238G>A, IL-1a - 889C>T and IL-10 - 1082G>A genetic polymorphisms with atopic diseases: asthma, rhinitis, dermatitis. Int Arch Allergy Immunol. 2016; 169: 231-240.; Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991; 173: 209-219.; Shmarina G, Pukhalsky A, Petrova N, et al. TNF gene polymorphisms in cystic fibrosis patients: contribution to the disease progression. J TranslMed. 2013; 11: 19-26.; Hull J, Thomson AH. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax. 1998; 53: 1018-1021.; Bitam S, Pranke I, Hollenhorst M, et al. An unexpected effect of TNF-a on F508del-CFTR maturation and function. F1000Research. 2015; 4: 218-233.; Shmitt-Grohe S, Stuber F, Book M, et al. TNF-alpha polymorphism in relation to TNF-alpha production and clinical status in Cystic Fibrosis. Lung. 2006; 184: 99-104.; Arkwright PD, Pravica V, Geraghty PJ, et al. End-organ dysfunction in cystic fibrosis. Am J Crit Care Med. 2003; 167: 384-389.; Baghel K, Srivastava RN, Chandra A, et al. Tumor necrosis factor-b Nco1 polymorphism and susceptibility to sepsis following major elective surgery. Surg Infect. 2014; 15(3): 213-220.; Kallaur AP, Oliveira SR, Simao ANC, et al. Tumor necrosis factor beta NcoI polymorphism is associated with inflammatory and metabolic markers in multiple sclerosis patients. J Neurol Sci. 2014; 346(1-2): 156-163.; de Sousa Parreira J, Kallaur AP, Lehmann MF, et al. Tumor necrosis factor beta NcoI polymorphism (rs909253) is associated with inflammatory and metabolic markers in acute ischemic stroke. Metab Brain Dis. 2014; 30(1): 159-167.; Shakera OG, Alnoury AM, Hegazy GA, et al. Methylene tetrahydrofolate reductase, transforming growth factor-b1 and lymphotoxin-a genes polymorphisms and susceptibility to rheumatoid arthritis. Rev Bras Reumatol. 2016; 56(5): 414-420.; Lopez-Collazo E, del Fresno C. Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences. Crit Care. 2013; 17(6): 242-252.; Sipka S, Bruckner G. The immunomodulatory role of bile acids. Int Arch Allergy Immunol. 2014; 165(1):1-8.; del Campo R, Martinez E, del Fresno C, et al. Translocated LPS might cause endotoxin tolerance in circulating monocytes of cystic fibrosis patients. PLoS One. 2011; 6(12): e29577.; Yamada A, Ichihara S, Murase Y, et al. Lack of association of polymorphisms of the lymphotoxin a gene with myocardial infarction in Japanese. J Mol Med. 2004; 82: 477-483.; Hamid YH, Urhammer SA, Glumer C, et al. The common T60N polymorphism of the lymphotoxin-a gene is associated with type 2 diabetes and other phenotypes of the metabolic syndrome. Diabetologia. 2005; 48:445-451.; Nishimura M, Obayashi H, Mizuta I, et al. TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol. 2003; 64(2):302-309.; Stayoussef M, AI-Jenaidi FA, AI-Abbasi A, et al. Modulation of type 1 diabetes susceptibility by tumor necrosis factor alpha -308 G/A and lymphotoxin alpha +249 A/G haplotypes and lack of linkage disequilibrium with predisposing DQB1-DRB1 haplotypes in Bahraini patients. Clin Vaccine Immunol. 2008 Feb; 15(2):379-381.; Stayoussef M, Zidi I, Mansour JB, et al. Association of lymphotoxin alpha polymorphism with type 1 diabetes in a Tunisian population. Biochem Genet. 2014; 52(1-2): 79-89.
Availability: https://www.medgen-journal.ru/jour/article/view/228
-
2Academic Journal
Authors: R. B. Aitnazarov, E. V. Ignatieva, N. E. Bazarova, V. G. Levitsky, S. P. Knyazev, Y. Gon, N. S. Yudin, Р. Б. Айтназаров, Е. В. Игнатьева, Н. Э. Базарова, В. Г. Левицкий, С. П. Князев, Я. Гон, Н. С. Юдин
Source: Vavilov Journal of Genetics and Breeding; Том 19, № 6 (2015); 699-706 ; Вавиловский журнал генетики и селекции; Том 19, № 6 (2015); 699-706 ; 2500-3259
Subject Terms: сайт связывания транскрипционного фактора, pig, wild boar, gene, lymphotoxin beta, single nucleotide polymorphism, SNP, transcription, transcription factor binding site, свинья, дикий кабан, ген, лимфотоксин бета, однонуклеотидный полиморфизм, транскрипция
File Description: application/pdf
Relation: https://vavilov.elpub.ru/jour/article/view/487/815; Айтназаров Р.Б., Юдин Н.С., Никитин С.В., Ермолаев В.И., Воевода М.И. Идентификация полноразмерных геномов эндогенных ретровирусов у сибирских мини-свиней. Вавиловский журнал генетики и селекции. 2014;18(2):294-297.; Беляев Д.К. Дестабилизирующий отбор как фактор изменчивости при доместикации. Природа. 1979;2:36-45.; Беляев Д.К. Дестабилизирующий отбор как фактор доместикации. Генетика и благосостояние человечества. М., 1981:53-66.; Игнатьева Е.В., Подколодная О.А., Орлов Ю.Л., Васильев Г.В., Колчанов Н.А. Регуляторная геномика – экспериментально-компьютерные подходы. Генетика. 2015;51(4):409-429.; Меркулова Т.И., Ананько Е.А., Игнатьева Е.В., Колчанов Н.А. Регуляторные коды транскрипции геномов эукариот. Генетика. 2013;49(1):37-54.; Недоспасов С.А., Купраш Д.В. Фактор некроза опухолей и лимфотоксин: физиологические функции и значение для цитокиновой и антицитокиновой терапии. Русский мультидисциплинарный журнал. 2008;12(1):69-76.; Трапезов О.В. Дарвинизм и уроки практической селекции в России. Вавиловский журнал генетики и селекции. 2009;13(2):249-297.; Ananko E.A., Kondrakhin Y.V., Merkulova T.I., Kolchanov N.A. Recognition of interferon-inducible sites, promoters, and enhancers. BMC Bioinformatics. 2007;8:56.; Ardia D.R., Parmentier H.K., Vogel L.A. The role of constraints and limitation in driving individual variation in immune response. Functional Ecology. 2011;25(1):61-73. DOI 10.1111/j.1365-2435.2010. 01759.x; Balenger S.L., Zuk M. Testing the Hamilton-Zuk hypothesis: past, present, and future. Integr Comp. Biol. 2014;54(4):601-613. DOI 10.1093/icb/icu059; Corre S., Galibert M.D. USF as a key regulatory element of gene expression. Med. Sci. (Paris). 2006;22(1):62-67.; Crooks G.E., Hon G., Chandonia J.M., Brenner S.E. WebLogo: a sequence logo generator. Genome Res. 2004;14(6):1188-1190.; Crowe P.D., VanArsdale T.L., Walter B.N., Ware C.F., Hession C., Ehrenfels B., Browning J.L., Din W.S., Goodwin R.G., Smith C.A. A lymphotoxin-beta-specific receptor. Science. 1994;264(5159):707-710.; Cui C.Y., Hashimoto T., Grivennikov S.I., Piao Y., Nedospasov S.A., Schlessinger D. Ectodysplasin regulates the lymphotoxin-beta pathway for hair differentiation. Proc. Natl Acad. Sci. USA. 2006; 103(24):9142-9147.; Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., Tanzer A., Lagarde J., Lin W., Schlesinger F., Xue C., Marinov G.K., Khatun J., Williams B.A., Zaleski C., Rozowsky J., Röder M., Kokocinski F., Abdelhamid R.F., Alioto T., Antoshechkin I., Baer M. T., Bar N.S., Batut P., Bell K., Bell I., Chakrabortty S., Chen X., Chrast J., Curado J., Derrien T., Drenkow J., Dumais E., Dumais J., Duttagupta R., Falconnet E., Fastuca M., Fejes-Toth K., Ferreira P., Foissac S., Fullwood M.J., Gao H., Gonzalez D., Gordon A., Gunawardena H., Howald C., Jha S., Johnson R., Kapranov P., King B., Kingswood C., Luo O.J., Park E., Persaud K., Preall J.B., Ribeca P., Risk B., Robyr D., Sammeth M., Schaffer L., See L.H., Shahab A., Skancke J., Suzuki A.M., Takahashi H., Tilgner H., Trout D., Walters N., Wang H., Wrobel J., Yu Y., Ruan X., Hayashizaki Y., Harrow J., Gerstein M., Hubbard T., Reymond A., Antonarakis S.E., Hannon G., Giddings M.C., Ruan Y., Wold B., Carninci P., Guigó R., Gingeras T.R. Landscape of transcription in human cells. Nature. 2012;489(7414):101-108. DOI 10.1038/nature11233; Ellmann L., Joshi M.B., Resink T.J., Bosserhoff A.K., Kuphal S. BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells. Lab Invest. 2012;92(12):1788-1800. DOI 10.1038/labinvest.2012.140; Fontes J.D., Jabrane-Ferrat N., Peterlin B.M. Assembly of functional regulatory complexes on MHC class II promoters in vivo. J. Mol. Biol. 1997;270(3):336-345.; Goodall J., Martinozzi S., Dexter T.J., Champeval D., Carreira S., Larue L., Goding C.R. Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin. Mol. Cell Biol. 2004;24(7):2915-2922.; Heringstad B., Chang Y.M., Gianola D., Klemetsdal G. Genetic association between susceptibility to clinical mastitis and protein yield in norwegian dairy cattle. J. Dairy Sci. 2005;88(4):1509-1514.; Heringstad B., Klemetsdal G., Steine T. Selection responses for disease resistance in two selection experiments with Norwegian red cows. J. Dairy Sci. 2007;90(5):2419-2426.; Hess J., Angel P., Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 2004;117(25):5965-5973.; Kel-Margoulis O.V., Romashchenko A.G., Kolchanov N.A., Wingender E., Kel A.E. COMPEL: a database on composite regulatory elements providing combinatorial transcriptional regulation. Nucl. Acids Res. 2000;28(1):311-315.; Kessler D.S., Veals S.A., Fu X.Y., Levy D.E. Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev. 1990;4(10):1753-1765.; Kim J.Y., Moon S.M., Ryu H.J., Kim J.J., Kim H.T., Park C., Kim K., Oh B., Lee J.K. Identification of regulatory polymorphisms in the TNF-TNF receptor superfamily. Immunogenetics. 2005;57(5): 297-303.; Kolchanov N.A., Ignatieva E.V., Ananko E.A., Podkolodnaya O.A., Stepanenko I.L., Merkulova T.I., Pozdnyakov M.A., Podkolodny N. L., Naumochkin A.N., Romashchenko A.G. Transcription regulatory regions database (TRRD): its status in 2002. Nucl. Acids Res. 2002;30(1):312-317.; Levitsky V.G., Ignatieva E.V., Ananko E.A., Turnaev I.I., Merkulova T. I., Kolchanov N.A., Hodgman T.C. Effective transcription factor binding site prediction using a combination of optimization, a genetic algorithm and discriminant analysis to capture distant interactions. BMC Bioinformatics. 2007;8:481.; Loos R.J., Yeo G.S. The bigger picture of FTO: the first GWAS-identified obesity gene. Nat. Rev. Endocrinol. 2014;10(1):51-61. DOI 10.1038/nrendo.2013.227; Mittelstadt M.L., Patel R.C. AP-1 mediated transcriptional repression of matrix metalloproteinase-9 by recruitment of histone deacetylase 1 in response to interferon β. PLoS One. 2012;7(8):e42152. DOI 10.1371/journal.pone.0042152; Nakamura T., Tashiro K., Nazarea M., Nakano T., Sasayama S., Honjo T. The murine lymphotoxin-beta receptor cDNA: isolation by the signal sequence trap and chromosomal mapping. Genomics. 1995; 30(2):312-319.; Onder L., Danuser R., Scandella E., Firner S., Chai Q., Hehlgans T., Stein J.V., Ludewig B. Endothelial cell-specific lymphotoxin-β receptor signaling is critical for lymph node and high endothelial venule formation. J. Exp. Med. 2013;210(3):465-473. DOI 10.1084/ jem.20121462; Seddon J.M., Berggren K.T., Fleeman L.M. Evolutionary history of DLA class II haplotypes in canine diabetes mellitus through single nucleotide polymorphism genotyping. Tissue Antigens. 2010;75(3):218-226. DOI 10.1111/j.1399-0039.2009.01426.x; Sheldon B.C., Verhulst S. Ecological immunology: costly parasite defences and trade-offs in evolutionary ecology. Trends Ecol. Evol. 1996;11(8):317-321.; Tierney R., Kirby H., Nagra J., Rickinson A., Bell A. The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5. J. Virol. 2000;74(22):10458-10467.; van der Most P.J., de Jong B., Parmentier H.K., Verhulst S. Trade-off between growth and immune function: a meta-analysis of selection experiments. Funct. Ecol. 2011;25(1):74-80. DOI 10.1111/j.1365-2435.2010.01800.x; Zhao F.Q. Octamer-binding transcription factors: genomics and functions. Front Biosci. 2013;18:1051-1071.; Zhang G., Li C., Li Q., Li B., Larkin D.M., Lee C., Storz J.F., Antunes A., Greenwold M.J., Meredith R.W., Ödeen A., Cui J., Zhou Q., Xu L., Pan H., Wang Z., Jin L., Zhang P., Hu H., Yang W., Hu J., Xiao J., Yang Z., Liu Y., Xie Q., Yu H., Lian J., Wen P., Zhang F ., Li H., Zeng Y ., Xiong Z., Liu S., Zhou L., Huang Z., An N., Wang J., Zheng Q., Xiong Y., Wang G., Wang B., Wang J., Fan Y., da Fonseca R.R., Alfaro-Núñez A., Schubert M., Orlando L., Mourier T., Howard J.T., Ganapathy G., Pfenning A., Whitney O., Rivas M.V., Hara E., Smith J., Farré M., Narayan J., Slavov G., Romanov M. N., Borges R., Machado J.P., Khan I., Springer M.S., Gatesy J., Hoffmann F.G., Opazo J.C., Håstad O., Sawyer R.H., Kim H., Kim K. W., Kim H.J., Cho S., Li N., Huang Y., Bruford M. W., Zhan X., Dixon A., Bertelsen M.F., Derryberry E., Warren W., Wilson R.K., Li S., Ray D.A., Green R.E., O’Brien S.J., Griffin D., Johnson W.E., Haussler D., Ryder O.A., Willerslev E., Graves G.R., Alström P., Fjeldså J., Mindell D.P., Edwards S.V., Braun E.L., Rahbek C., Burt D.W., Houde P., Zhang Y., Yang H., Wang J., Avian Genome Consortium; Jarvis E.D., Gilbert M.T., Wang J. Comparative genomics reveals insights into avian genome evolution and adaptation. Science. 2014;346(6215):1311-1320. DOI 10.1126/science.1251385; https://vavilov.elpub.ru/jour/article/view/487
-
3Academic Journal
Authors: Митин, Александр, Друцкая, М., Литвина, М., Зварцев, Р., Комогорова, В., Шарова, Н., Донецкова, А., Никонова, М., Недоспасов, С., Ярилин, А.
Subject Terms: ФНО, ЛИМФОТОКСИН, Т-ЛИМФОЦИТЫ, ВТОРИЧНЫЕ ЛИМФОИДНЫЕ ОРГАНЫ
File Description: text/html
-
4Academic Journal
Authors: Белоусова, О.
Subject Terms: ГЕНЫ ФАКТОРОВ НЕКРОЗА ОПУХОЛИ,РЕЦЕПТОРЫ ФАКТОРОВ НЕКРОЗА ОПУХОЛИ,ЛИМФОТОКСИН А,САХАРНЫЙ ДИАБЕТ 2 ТИПА,ПАТОГЕНЕТИЧЕСКИЕ ЭФФЕКТЫ
File Description: text/html
-
5Academic Journal
Authors: Кривошей, И. В.
Subject Terms: медицина, внутренние болезни, гипертоническая болезнь, гипертония, медицинская генетика, липидный спектр, полиморфизм генов, генетический полиформизм, лимфотоксин, исследования
Availability: http://dspace.bsu.edu.ru/handle/123456789/13242
-
6Academic Journal
Source: Иммунология.
Subject Terms: 03 medical and health sciences, 0302 clinical medicine, ФНО, ЛИМФОТОКСИН, Т-ЛИМФОЦИТЫ, ВТОРИЧНЫЕ ЛИМФОИДНЫЕ ОРГАНЫ
File Description: text/html
-
7Academic Journal
-
8Academic Journal
Source: Научные ведомости Белгородского государственного университета. Серия: Медицина. Фармация.
Subject Terms: ГЕНЫ ФАКТОРОВ НЕКРОЗА ОПУХОЛИ,РЕЦЕПТОРЫ ФАКТОРОВ НЕКРОЗА ОПУХОЛИ,ЛИМФОТОКСИН А,САХАРНЫЙ ДИАБЕТ 2 ТИПА,ПАТОГЕНЕТИЧЕСКИЕ ЭФФЕКТЫ
File Description: text/html
-
9
Authors: Крикун, Я. Е.
Subject Terms: медицина, медицинская генетика, гены, лимфотоксин, генетический полиморфизм, полиморфизм, полиморфизм генов, Россия, Центральное Черноземье, мультифакториальные заболевания
Availability: http://dspace.bsu.edu.ru/handle/123456789/13379
-
10Electronic Resource
-
11Electronic Resource
-
12Electronic Resource
Authors: Кривошей, И. В.
